Molecular Partners AG Stock Analysis & AI Score
Molecular Partners AG (MOLN) has an ST Score of 49.6 (C+), driven by its Forecast (A) and held back by its Profitability (D+). Analysts rate it Hold with a $21.00 price target (+401.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Molecular Partners AG (MOLN) has an ST Score of 49.6 (C+), driven by its Forecast (A) and held back by its Profitability (D+). Analysts rate it Hold with a $21.00 price target (+401.2% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityD+
All factor grades
- ForecastA
- MomentumA-
- ValuationB
- Financial StrengthC
- GrowthC
- ProfitabilityD+
- Piotroski1/9
Contact
MOLN stock: frequently asked questions
What is MOLN's ST Score?
Molecular Partners AG (MOLN) has an ST Score of 49.6 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is MOLN a buy, hold, or sell?
Analysts rate MOLN a Hold, with a price target of $21.00 (+401.2% vs the current price). Our ST Score grades it C+ (49.6/100). The ST Score is a data-driven signal, not a recommendation.
What are MOLN's factor grades?
Valuation B, Profitability D+, Financial Strength C, Momentum A-, Growth C, Forecast A.
What is MOLN's valuation grade?
Molecular Partners AG (MOLN) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is MOLN's growth grade?
Molecular Partners AG (MOLN) earns a growth grade of C, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is MOLN's profitability grade?
Molecular Partners AG (MOLN) earns a profitability grade of D+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is MOLN's financial strength grade?
Molecular Partners AG (MOLN) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for MOLN?
The average analyst price target for Molecular Partners AG (MOLN) is $21.00 from 4 analysts, which is +401.2% versus the recent price of $4.19.
What is MOLN's Piotroski score?
Molecular Partners AG (MOLN) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.